We care about your data, and we'd like to use cookies to give you a smooth browsing experience.

Please agree and read more about

our privacy policy. AGREE

A BST R AC T I O N S B LOG

Biodiversity Alters Strategies of Bacterial Evolution

By J O R D A N A C E P E L E W I C Z

January 6, 2020

In evolution, context is everything: Bacteria with neighbors evolve to rebu� viruses in a di�erent way.

A bacteriophage virus (orange) latches onto the surface of a bacterial cell. Only moments before, the
virus injected its DNA into the bacterium to infect it.

Biozentrum, University of Basel / Science Photo Library

 I
n the closing paragraph of On the Origin of Species, Charles Darwin urged readers to “contemplate
We care about your data, and we'd like to use cookies to give you a smooth browsing experience. Please agree and read more about
a tangled bank, clothed with many plants of many kinds, with birds singing on the bushes, with
our privacy policy. AGREE
various insects �itting about, and with worms crawling through the damp earth.” Those plants, birds,
insects and worms, he continued, all evolved as they did because of the complex web of ecological
factors in which they’d been embedded. Had the temperature been hotter, the water more acidic or a
certain species of grass absent, a very di�erent “tangled bank” might have evolved instead.

Researchers have typically tried to tease out the evolutionary e�ects of environmental factors one by
one. But the full biodiversity of an environment — the entirety of the tangled bank itself — can also be
a crucial in�uence on how a species evolves.

Recently, a paper published in Nature found that when a bacterial species resides in even a very simple
ecological community — one that includes just a few other kinds of microbes — it evolves very
di�erent defense strategies against a predatory bacteriophage virus than it does when it’s left alone
with the phage. The research “is expanding these ideas into the context of the microbiome, where
bacteria exist alongside loads of other species,” said Michael Brockhurst, an evolutionary biologist at
the University of She�eld in England who was not involved with the study.

The �nding not only elevates the value of biodiversity as an evolutionary factor in its own right, but
suggests that some earlier conclusions about the behaviors and capabilities of microorganisms, drawn
from laboratory studies of species in isolation, may be seriously incomplete. It also sounds a note of
caution about some contemplated strategies for beating drug resistance in bacteria.

Resistance by Any Means Necessary

Scientists often turn to bacteria and the bacteriophage viruses that prey on them to learn about
coevolution. Both are locked in an eternal, rapid-�re evolutionary con�ict that can be controlled and
measured in the laboratory.

Eons ago, bacteria (or their archaea cousins) evolved a clever system for thwarting viruses: the
genomic feature called CRISPR, which has become famous in the past decade as a tool of biotechnology.
CRISPR acts like an adaptive immune system; it enables bacteria that have been exposed to a virus to
pass on a genetic “memory” of that infection to their descendants, which can then mount better
defenses against a repeat infection. It’s a system that works so well that an estimated half of all
bacterial species use CRISPR.

What puzzles many microbiologists, though, is why some bacteria use CRISPR and others don’t.
CRISPR-equipped bacteria are scattered throughout the bacterial kingdom almost randomly, and even
the bacteria with CRISPR in their genomes don’t consistently rely on it.

Researchers have uncovered dozens of other systems that bacteria use to rebu� phage invasions. But in
laboratory studies, bacteria primarily develop what’s known as surface-based phage resistance.
Mutations change receptor molecules on the surface of the bacterial cell, so that the phage can no
longer recognize and invade it.

The strategy is akin to shutting a door and throwing away the key: It o�ers the bacteria complete safety
from infection by the virus. But that protection comes at a signi�cant price, because it also disrupts
whatever nutrient uptake, waste disposal, communication task or other cellular function the receptor
would have been providing — taking a constant toll on a cell’s �tness.
 In contrast, CRISPR only drags on a cell’s resources when it’s active, during a viral infection. Even so,
We care about your data, and we'd like to use cookies to give you a smooth browsing experience. Please agree and read more about
CRISPR represents a riskier gambit: It doesn’t start to work until phages have already entered the cell,
our privacy policy. AGREE
meaning that there’s a chance the viruses could overcome it. And CRISPR doesn’t just attack viral DNA;
it can also prevent bacteria from taking up bene�cial genes from other microbes, like those that confer
antibiotic resistance.

What factors a�ect the trade-o�s in costs and �tness? For the past six years, Edze Westra, an
evolutionary ecologist at the University of Exeter in England, has led a team pursuing the answer to
that question. In 2015, they discovered that nutrient availability and phage density a�ected whether
Pseudomonas bacteria relied on surface-based or CRISPR-based resistance. In environments poor in
resources, receptor modi�cations were more burdensome, so CRISPR became a better bargain. When
resources were plentiful, bacteria grew more densely and phage epidemics became more frequent.
Bacteria then faced greater selective pressure to close themselves o� from infection entirely, and so
they shut down receptors to gain surface-based resistance.

This explained why surface-based resistance was so common in laboratory cultures. Growing in a test
tube rich in nutrients, “these bacteria are on a holiday,” Westra said. “They are having a terri�c time.”

Still, these rules weren’t cut and dried. Plenty of bacteria in natural high-nutrient environments use
CRISPR, and plenty of bacteria in natural low-nutrient environments don’t. “It’s all over the place,”
Westra said. “That told us that we were probably still missing something.”

How Biodiversity Reshapes the Battle

Then one of Westra’s graduate students, Ellinor Opsal, proposed another potential factor: the diversity
of the biological communities in which bacteria live. This factor is harder to study, but scientists had
previously observed that it could a�ect phage immunity in bacteria. For example, in 2005, James Bull, a
biologist at the University of Texas, Austin, and William Harcombe, his graduate student at the time
(now at the University of Minnesota), found that E. coli bacteria didn’t evolve immunity to a phage
when a second bacterial species was present. Similarly, Britt Koskella, an evolutionary biologist at the
University of California, Berkeley, and one of her graduate students, Catherine Hernandez, reported
last year that phage resistance failed to arise in Pseudomonas bacteria living on their actual host (a
plant), though they always gained immunity in a test tube. Could the diversity of the surroundings
in�uence not just whether or not resistance to phages evolved, but the nature of that resistance?
We care about your data, and we'd like to use cookies to give you a smooth browsing experience. Please agree and read more about

our privacy policy. AGREE

In this scanning electron micrograph, cells of the bacterium Pseudomonas aeruginosa (green) grow on
ciliated cells in the human nose.

Juergen Berger/ Science Photo Library

 To �nd out, Westra’s team performed a new set of experiments: Instead of altering the nutrient
We care about your data, and we'd like to use cookies to give you a smooth browsing experience. Please agree and read more about
conditions for Pseudomonas bacteria growing with phages, they added three other bacterial species —
our privacy policy. AGREE
species that competed against Pseudomonas for resources but weren’t targeted by the phage.

Left to themselves, Pseudomonas would normally develop surface-based mutations. But in the
company of rivals, they were far more likely to turn to CRISPR. Further investigation showed that the
more complex community dynamics had shifted the �tness costs: The bacteria could no longer a�ord
to inactivate receptors because they not only had to survive the phage, but also had to outcompete the
bacteria around them.

These results from Westra’s group dovetail with earlier �ndings that phages can produce greater
diversity in bacterial communities. “Now, that diversity is actually feeding back to the phage side of
things” by a�ecting phage resistance, Koskella said. “It’s neat to see that coming full circle.” By
understanding that kind of feedback loop, she added, “we can start to ask more general questions
about the impacts that phages have in a community context.”

For one, the bacteria’s shift toward a CRISPR-based phage response had another, broader e�ect. When
Westra’s group grew Pseudomonas in moth larvae hosts, they found that the bacteria with surface-
based resistance were less virulent, killing the larvae much more slowly than the bacteria with active
CRISPR systems did.

These results have direct implications for phage therapy, an approach to �ghting bacterial infections
that is gaining interest among researchers. Scientists like Paul Turner, an ecologist and evolutionary
biologist at Yale University, are seeking out phages that would induce receptor mutations in targeted
bacteria to make them less virulent or more susceptible to antibiotics. But if the evolution of CRISPR-
based resistance is an option for the bacteria, that strategy “might not always work in a more complex
community,” Turner said. (He acknowledged that this hasn’t yet surfaced as a problem in phage
therapy experiments).

Westra’s team, along with other groups, is now studying these e�ects in other bacterial systems and
environments, and for other types of immunity. They’re also exploring how di�erent types of
microbial diversity a�ect the evolution of phage resistance in bacteria. Meanwhile, Harcombe and his
colleagues are studying how evolution proceeds in communities where bacterial species cooperate and
rely on each other for survival instead of competing, such as the microbiome in the human gut.

Others are looking at evolutionary traits beyond phage resistance. In a paper published in August, a
team of researchers found that greater biodiversity prevented the spread of certain antibiotic
resistance genes.

Perhaps most important, these �ndings give scientists insights into the level of complexity they might
need for their experiments going forward. “A lot of the stu� that we think we know about bacteria and
phage and how they interact comes from these really simple test tube experiments,” Westra said. “And
these results just don’t hold if we start to introduce some real-life ecological complexity. We have to
take the environmental realism into account” — even if it is a much more di�cult endeavor.

“That’s going to be really critical,” Harcombe said, “as we try to manage microbiomes and as we try to
manage ecosystems in a changing world.”
We care about your data, and we'd like to use cookies to give you a smooth browsing experience. Please agree and read more about

our privacy policy. AGREE